share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

福泰製藥 | 144：擬議出售證券
美股sec公告 ·  06/04 01:41
牛牛AI助理已提取核心訊息
Vertex Pharmaceuticals Inc. officer, Tatsis Ourania, is set to sell 2,175 shares of common stock on 06/03/2024, with an aggregate market value of approximately $1,000,500. The shares to be sold were acquired through restricted stock vesting as part of compensation on two separate occasions, with 740 shares acquired on 02/17/2024 and an additional 1,435 shares on 02/20/2024, both from the issuer. This planned sale follows a recent transaction history where a total of 4,600 shares were sold over the past three months, generating gross proceeds of $2,033,158.5.
Vertex Pharmaceuticals Inc. officer, Tatsis Ourania, is set to sell 2,175 shares of common stock on 06/03/2024, with an aggregate market value of approximately $1,000,500. The shares to be sold were acquired through restricted stock vesting as part of compensation on two separate occasions, with 740 shares acquired on 02/17/2024 and an additional 1,435 shares on 02/20/2024, both from the issuer. This planned sale follows a recent transaction history where a total of 4,600 shares were sold over the past three months, generating gross proceeds of $2,033,158.5.
vertex pharmaceuticals inc. 職員Tatsis Ourania計劃於06/03/2024賣出2,175股普通股，市值約為$1,000,500。這些股票是通過兩次獲取限制性股票解禁並作為報酬的一部分分別於02/17/2024和02/20/2024從發行人處獲得，共計740股和1,435股。這次計劃銷售是繼過去三個月內出售4,600股獲得$2,033,158.5毛收益之後進行的。
vertex pharmaceuticals inc. 職員Tatsis Ourania計劃於06/03/2024賣出2,175股普通股，市值約為$1,000,500。這些股票是通過兩次獲取限制性股票解禁並作為報酬的一部分分別於02/17/2024和02/20/2024從發行人處獲得，共計740股和1,435股。這次計劃銷售是繼過去三個月內出售4,600股獲得$2,033,158.5毛收益之後進行的。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。